JP2003081797A - Composition for the oral cavity - Google Patents
Composition for the oral cavityInfo
- Publication number
- JP2003081797A JP2003081797A JP2002196718A JP2002196718A JP2003081797A JP 2003081797 A JP2003081797 A JP 2003081797A JP 2002196718 A JP2002196718 A JP 2002196718A JP 2002196718 A JP2002196718 A JP 2002196718A JP 2003081797 A JP2003081797 A JP 2003081797A
- Authority
- JP
- Japan
- Prior art keywords
- sodium
- weight
- general formula
- sulfosuccinic acid
- based surfactant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 45
- 210000000214 mouth Anatomy 0.000 title abstract 3
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 claims abstract description 36
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 claims abstract description 31
- 239000004094 surface-active agent Substances 0.000 claims abstract description 27
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims abstract description 23
- 229940013618 stevioside Drugs 0.000 claims abstract description 23
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims abstract description 23
- 235000019202 steviosides Nutrition 0.000 claims abstract description 23
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 21
- 229940011037 anethole Drugs 0.000 claims abstract description 18
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 claims abstract description 18
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 claims abstract description 18
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 claims abstract description 18
- 235000012141 vanillin Nutrition 0.000 claims abstract description 18
- GTOFKXZQQDSVFH-UHFFFAOYSA-N 2-benzylsuccinic acid Chemical compound OC(=O)CC(C(O)=O)CC1=CC=CC=C1 GTOFKXZQQDSVFH-UHFFFAOYSA-N 0.000 claims abstract description 17
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229940085605 saccharin sodium Drugs 0.000 claims abstract description 14
- 229910052783 alkali metal Inorganic materials 0.000 claims abstract description 8
- 150000001340 alkali metals Chemical class 0.000 claims abstract description 8
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 7
- 125000005702 oxyalkylene group Chemical group 0.000 claims abstract description 6
- 229910052708 sodium Inorganic materials 0.000 claims description 16
- 239000011734 sodium Substances 0.000 claims description 16
- 125000004432 carbon atom Chemical group C* 0.000 claims description 15
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 14
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 4
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 3
- 150000001342 alkaline earth metals Chemical class 0.000 claims description 3
- 235000019658 bitter taste Nutrition 0.000 abstract description 16
- 230000015572 biosynthetic process Effects 0.000 abstract description 12
- 150000001875 compounds Chemical class 0.000 abstract description 9
- -1 cocoyl Chemical group 0.000 description 38
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 22
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 21
- 235000002639 sodium chloride Nutrition 0.000 description 19
- 150000003839 salts Chemical class 0.000 description 17
- 239000013543 active substance Substances 0.000 description 16
- 230000000694 effects Effects 0.000 description 10
- 239000000377 silicon dioxide Substances 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 239000003205 fragrance Substances 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 8
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 8
- 239000003945 anionic surfactant Substances 0.000 description 7
- 239000000551 dentifrice Substances 0.000 description 7
- 235000014113 dietary fatty acids Nutrition 0.000 description 7
- JMGZBMRVDHKMKB-UHFFFAOYSA-L disodium;2-sulfobutanedioate Chemical compound [Na+].[Na+].OS(=O)(=O)C(C([O-])=O)CC([O-])=O JMGZBMRVDHKMKB-UHFFFAOYSA-L 0.000 description 7
- 239000000194 fatty acid Substances 0.000 description 7
- 229930195729 fatty acid Natural products 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- 239000000606 toothpaste Substances 0.000 description 7
- 229940034610 toothpaste Drugs 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 229940079886 disodium lauryl sulfosuccinate Drugs 0.000 description 6
- KHIQYZGEUSTKSB-UHFFFAOYSA-L disodium;4-dodecoxy-4-oxo-3-sulfobutanoate Chemical compound [Na+].[Na+].CCCCCCCCCCCCOC(=O)C(S(O)(=O)=O)CC([O-])=O.CCCCCCCCCCCCOC(=O)C(S(O)(=O)=O)CC([O-])=O KHIQYZGEUSTKSB-UHFFFAOYSA-L 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 5
- 239000012190 activator Substances 0.000 description 5
- 239000004359 castor oil Substances 0.000 description 5
- 235000019438 castor oil Nutrition 0.000 description 5
- 238000013329 compounding Methods 0.000 description 5
- 238000007796 conventional method Methods 0.000 description 5
- 235000003599 food sweetener Nutrition 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 239000000419 plant extract Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000003765 sweetening agent Substances 0.000 description 5
- 230000008719 thickening Effects 0.000 description 5
- 239000000341 volatile oil Substances 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 4
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 4
- 244000228451 Stevia rebaudiana Species 0.000 description 4
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 239000011230 binding agent Substances 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 239000003086 colorant Substances 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 4
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 4
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000003082 abrasive agent Substances 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 3
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 239000000417 fungicide Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 3
- 239000002324 mouth wash Substances 0.000 description 3
- 229940051866 mouthwash Drugs 0.000 description 3
- 239000003002 pH adjusting agent Substances 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000000080 wetting agent Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- QZXSMBBFBXPQHI-UHFFFAOYSA-N N-(dodecanoyl)ethanolamine Chemical compound CCCCCCCCCCCC(=O)NCCO QZXSMBBFBXPQHI-UHFFFAOYSA-N 0.000 description 2
- ZYEMGPIYFIJGTP-UHFFFAOYSA-N O-methyleugenol Chemical compound COC1=CC=C(CC=C)C=C1OC ZYEMGPIYFIJGTP-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 235000009499 Vanilla fragrans Nutrition 0.000 description 2
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- LFVVNPBBFUSSHL-UHFFFAOYSA-N alexidine Chemical compound CCCCC(CC)CNC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NCC(CC)CCCC LFVVNPBBFUSSHL-UHFFFAOYSA-N 0.000 description 2
- 229950010221 alexidine Drugs 0.000 description 2
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- 230000001680 brushing effect Effects 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 235000010216 calcium carbonate Nutrition 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 2
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- JOZKFWLRHCDGJA-UHFFFAOYSA-N citronellol acetate Chemical compound CC(=O)OCCC(C)CCC=C(C)C JOZKFWLRHCDGJA-UHFFFAOYSA-N 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 239000010643 fennel seed oil Substances 0.000 description 2
- 239000004088 foaming agent Substances 0.000 description 2
- 239000000174 gluconic acid Substances 0.000 description 2
- 235000012208 gluconic acid Nutrition 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 125000006353 oxyethylene group Chemical group 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 230000001376 precipitating effect Effects 0.000 description 2
- 229940081974 saccharin Drugs 0.000 description 2
- 235000019204 saccharin Nutrition 0.000 description 2
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- 239000011775 sodium fluoride Substances 0.000 description 2
- 235000013024 sodium fluoride Nutrition 0.000 description 2
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 2
- 239000010676 star anise oil Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 229960003500 triclosan Drugs 0.000 description 2
- 235000013799 ultramarine blue Nutrition 0.000 description 2
- 229940117960 vanillin Drugs 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 1
- KRLBLPBPZSSIGH-CSKARUKUSA-N (6e)-3,7-dimethylnona-1,6-dien-3-ol Chemical compound CC\C(C)=C\CCC(C)(O)C=C KRLBLPBPZSSIGH-CSKARUKUSA-N 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- BRJJFBHTDVWTCJ-UHFFFAOYSA-N 1-[n'-[6-[[amino-[[n'-(2-ethylhexyl)carbamimidoyl]amino]methylidene]amino]hexyl]carbamimidoyl]-2-(2-ethylhexyl)guanidine;dihydrochloride Chemical compound Cl.Cl.CCCCC(CC)CN=C(N)NC(N)=NCCCCCCN=C(N)NC(N)=NCC(CC)CCCC BRJJFBHTDVWTCJ-UHFFFAOYSA-N 0.000 description 1
- GKQHIYSTBXDYNQ-UHFFFAOYSA-M 1-dodecylpyridin-1-ium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+]1=CC=CC=C1 GKQHIYSTBXDYNQ-UHFFFAOYSA-M 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- XLJNWPNOVKHJFK-UHFFFAOYSA-N 2-sulfo-2-tetradecylbutanedioic acid Chemical compound CCCCCCCCCCCCCCC(S(O)(=O)=O)(C(O)=O)CC(O)=O XLJNWPNOVKHJFK-UHFFFAOYSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 1
- JOZKFWLRHCDGJA-LLVKDONJSA-N Citronellyl acetate Natural products CC(=O)OCC[C@H](C)CCC=C(C)C JOZKFWLRHCDGJA-LLVKDONJSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 108010001682 Dextranase Proteins 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- RAXXELZNTBOGNW-UHFFFAOYSA-O Imidazolium Chemical compound C1=C[NH+]=CN1 RAXXELZNTBOGNW-UHFFFAOYSA-O 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 239000004115 Sodium Silicate Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 240000001717 Vaccinium macrocarpon Species 0.000 description 1
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 description 1
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 description 1
- 244000290333 Vanilla fragrans Species 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- VKTIOFKTYOYYOD-UHFFFAOYSA-L [Mg+2].S(=O)(=O)(O)C(C(=O)OCCCCCCCCCCCC)CC(=O)[O-].C(CCCCCCCCCCC)OC(C(CC(=O)[O-])S(=O)(=O)O)=O Chemical compound [Mg+2].S(=O)(=O)(O)C(C(=O)OCCCCCCCCCCCC)CC(=O)[O-].C(CCCCCCCCCCC)OC(C(CC(=O)[O-])S(=O)(=O)O)=O VKTIOFKTYOYYOD-UHFFFAOYSA-L 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 125000004442 acylamino group Chemical group 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- OVKDFILSBMEKLT-UHFFFAOYSA-N alpha-Terpineol Natural products CC(=C)C1(O)CCC(C)=CC1 OVKDFILSBMEKLT-UHFFFAOYSA-N 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229940088601 alpha-terpineol Drugs 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000010617 anise oil Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 239000010619 basil oil Substances 0.000 description 1
- 229940018006 basil oil Drugs 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- XAAHAAMILDNBPS-UHFFFAOYSA-L calcium hydrogenphosphate dihydrate Chemical compound O.O.[Ca+2].OP([O-])([O-])=O XAAHAAMILDNBPS-UHFFFAOYSA-L 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 229960002152 chlorhexidine acetate Drugs 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 235000004634 cranberry Nutrition 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- FXNRKXSSLJKNGH-UHFFFAOYSA-L dipotassium;fluoro-dioxido-oxo-$l^{5}-phosphane Chemical compound [K+].[K+].[O-]P([O-])(F)=O FXNRKXSSLJKNGH-UHFFFAOYSA-L 0.000 description 1
- OTSBYOFHPTYOPR-BZKIHGKGSA-L disodium (Z)-octadec-9-enamide 2-sulfobutanedioate Chemical compound [Na+].[Na+].OS(=O)(=O)C(C([O-])=O)CC([O-])=O.CCCCCCCC\C=C/CCCCCCCC(N)=O OTSBYOFHPTYOPR-BZKIHGKGSA-L 0.000 description 1
- AQCOZQWOHGEEKY-UHFFFAOYSA-L disodium 4-oxo-3-sulfo-4-tetradecoxybutanoate Chemical compound S(=O)(=O)(O)C(C(=O)OCCCCCCCCCCCCCC)CC(=O)[O-].[Na+].[Na+].C(CCCCCCCCCCCCC)OC(C(CC(=O)[O-])S(=O)(=O)O)=O AQCOZQWOHGEEKY-UHFFFAOYSA-L 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 1
- DDXLVDQZPFLQMZ-UHFFFAOYSA-M dodecyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)C DDXLVDQZPFLQMZ-UHFFFAOYSA-M 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 108010000165 exo-1,3-alpha-glucanase Proteins 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 229910021485 fumed silica Inorganic materials 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052816 inorganic phosphate Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- FXPLXYZPNNSHTE-UHFFFAOYSA-L magnesium;2-sulfobutanedioate Chemical compound [Mg+2].OS(=O)(=O)C(C([O-])=O)CC([O-])=O FXPLXYZPNNSHTE-UHFFFAOYSA-L 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 229940116837 methyleugenol Drugs 0.000 description 1
- PRHTXAOWJQTLBO-UHFFFAOYSA-N methyleugenol Natural products COC1=CC=C(C(C)=C)C=C1OC PRHTXAOWJQTLBO-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000001627 myristica fragrans houtt. fruit oil Substances 0.000 description 1
- 150000007823 ocimene derivatives Chemical class 0.000 description 1
- 125000004365 octenyl group Chemical group C(=CCCCCCC)* 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- JJVNINGBHGBWJH-UHFFFAOYSA-N ortho-vanillin Chemical compound COC1=CC=CC(C=O)=C1O JJVNINGBHGBWJH-UHFFFAOYSA-N 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- MCSINKKTEDDPNK-UHFFFAOYSA-N propyl propionate Chemical compound CCCOC(=O)CC MCSINKKTEDDPNK-UHFFFAOYSA-N 0.000 description 1
- 229940029039 propylene glycol alginate ester Drugs 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 1
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 1
- AQMNWCRSESPIJM-UHFFFAOYSA-M sodium metaphosphate Chemical compound [Na+].[O-]P(=O)=O AQMNWCRSESPIJM-UHFFFAOYSA-M 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- 229950005425 sodium myristyl sulfate Drugs 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 229940048086 sodium pyrophosphate Drugs 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- 229910052911 sodium silicate Inorganic materials 0.000 description 1
- 235000019832 sodium triphosphate Nutrition 0.000 description 1
- UPUIQOIQVMNQAP-UHFFFAOYSA-M sodium;tetradecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCOS([O-])(=O)=O UPUIQOIQVMNQAP-UHFFFAOYSA-M 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 1
- 229960002799 stannous fluoride Drugs 0.000 description 1
- SFVFIFLLYFPGHH-UHFFFAOYSA-M stearalkonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 SFVFIFLLYFPGHH-UHFFFAOYSA-M 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000008054 sulfonate salts Chemical class 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000010677 tea tree oil Substances 0.000 description 1
- 229940111630 tea tree oil Drugs 0.000 description 1
- RYCLIXPGLDDLTM-UHFFFAOYSA-J tetrapotassium;phosphonato phosphate Chemical compound [K+].[K+].[K+].[K+].[O-]P([O-])(=O)OP([O-])([O-])=O RYCLIXPGLDDLTM-UHFFFAOYSA-J 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- UDEJEOLNSNYQSX-UHFFFAOYSA-J tetrasodium;2,4,6,8-tetraoxido-1,3,5,7,2$l^{5},4$l^{5},6$l^{5},8$l^{5}-tetraoxatetraphosphocane 2,4,6,8-tetraoxide Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P1(=O)OP([O-])(=O)OP([O-])(=O)OP([O-])(=O)O1 UDEJEOLNSNYQSX-UHFFFAOYSA-J 0.000 description 1
- 239000010678 thyme oil Substances 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- XJPBRODHZKDRCB-UHFFFAOYSA-N trans-alpha-ocimene Natural products CC(=C)CCC=C(C)C=C XJPBRODHZKDRCB-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 150000003712 vitamin E derivatives Chemical class 0.000 description 1
- 239000009637 wintergreen oil Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 150000003752 zinc compounds Chemical class 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- GFQYVLUOOAAOGM-UHFFFAOYSA-N zirconium(iv) silicate Chemical compound [Zr+4].[O-][Si]([O-])([O-])[O-] GFQYVLUOOAAOGM-UHFFFAOYSA-N 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、スルホコハク酸系
界面活性剤を配合した口腔用組成物に関する。TECHNICAL FIELD The present invention relates to an oral composition containing a sulfosuccinic acid surfactant.
【0002】[0002]
【従来の技術】ステインは、クロルヘキシジンなどの殺
菌剤、茶などに含まれるタンニン系物質、鉄などの金属
イオンが原因で起こると考えられている歯牙への色素沈
着物であり、審美上の大きな問題である。これを解決す
るための手段としてはステインを除去する方法と、ステ
インの形成を阻害する方法が考えられる。ステインを除
去するためには、一般に強い研磨剤や漂白剤が用いられ
ているが、これらにはそれぞれ歯牙を損傷する、刺激が
強いという問題点がある。これを解決する手段として、
スルホコハク酸系界面活性剤をステイン形成阻害剤とし
て口腔用組成物に用いることは特開平10−17443
号公報に開示されている。しかし、スルホコハク酸系界
面活性剤は苦味と活性剤臭が強く、単に口腔用組成物に
配合すると使用感を著しく損なうという問題点がある。2. Description of the Related Art Stain is a pigment deposit on teeth that is thought to be caused by bactericides such as chlorhexidine, tannin-based substances contained in tea, etc., and metal ions such as iron. It's a problem. As a means for solving this, a method of removing stains and a method of inhibiting the formation of stains can be considered. Although strong abrasives and bleaches are generally used to remove stains, these have the problems of damaging the teeth and strong irritation. As a means to solve this,
Use of a sulfosuccinic acid-based surfactant as a stain formation inhibitor in an oral composition is disclosed in JP-A-10-17443.
It is disclosed in the publication. However, the sulfosuccinic acid-based surfactant has a strong bitterness and a strong odor of the active agent, and if it is simply added to the oral composition, the use feeling is significantly impaired.
【0003】この問題点を解決するため、特開平12−
53547号公報には水溶性の2価の金属塩を配合する
ことが示されているが、苦味はおさえるものの泡立ちな
どの使用感が損なわれるという問題が発生する。特開2
000−319148号公報には、パラチニットを配合
することが示されているが、製造コストが上昇してしま
うという問題点がある。なお、これらの特許では、活性
剤臭の解決については言及されていない。In order to solve this problem, Japanese Patent Laid-Open No. 12-
Japanese Patent No. 53547 discloses that a water-soluble divalent metal salt is blended, but although bitterness is suppressed, a problem occurs in that the feeling of use such as foaming is impaired. JP 2
Japanese Patent Application Laid-Open No. 000-319148 discloses that palatinit is mixed, but there is a problem that the manufacturing cost increases. It should be noted that these patents do not mention the solution of the odor of the active agent.
【0004】[0004]
【発明が解決しようとする課題】本発明の目的は、ステ
イン形成を効果的に阻害するためにスルホコハク酸系界
面活性剤を配合し、且つスルホコハク酸系界面活性剤由
来の苦さと活性剤臭を改善する口腔用組成物を提供する
ことである。An object of the present invention is to incorporate a sulfosuccinic acid type surfactant in order to effectively inhibit stain formation, and to eliminate the bitterness and the odor of the active agent derived from the sulfosuccinic acid type surfactant. It is to provide an improved oral composition.
【0005】[0005]
【課題を解決するための手段】このような現状を鑑み、
本発明者らは鋭意研究を行った結果、サッカリンナトリ
ウムとステビオサイドを重量比で1:1〜8:1の割合
で合計が0.01〜1重量%、およびバニリン、アネト
ール、ベンジルサクシネートから選択される1種または
2種以上の香料化合物を配合すると、スルホコハク酸系
界面活性剤由来の苦味と活性剤臭が効果的に抑制される
ことを見出し、本発明を完成するに至った。
項1 一般式(1)で示されるスルホコハク酸系界面活
性剤の少なくとも1種を0.01〜5重量%、サッカリ
ンナトリウムとステビオサイドを重量比で1:1〜8:
1の割合で合計が0.01〜1重量%、並びにバニリ
ン、アネトール及びベンジルサクシネートから選択され
る少なくとも1種を配合した口腔用組成物。
一般式(1):[Means for Solving the Problems] In view of such a current situation,
As a result of intensive studies, the present inventors have found that saccharin sodium and stevioside are selected from vanillin, anethole, and benzyl succinate in a weight ratio of 1: 1 to 8: 1 in a total amount of 0.01 to 1% by weight. It was found that the bitterness and the odor of the active agent derived from the sulfosuccinic acid surfactant can be effectively suppressed by blending one or more kinds of the fragrance compounds described above, and the present invention has been completed. Item 1 0.01 to 5% by weight of at least one sulfosuccinic acid-based surfactant represented by the general formula (1), and sodium saccharin and stevioside in a weight ratio of 1: 1 to 8:
An oral composition containing 0.01 to 1% by weight in total of 1 and at least one selected from vanillin, anethole and benzyl succinate. General formula (1):
【0006】[0006]
【化2】 [Chemical 2]
【0007】[式中、X1及びX2のいずれか一方がR1
O−(AO)n− 又は R1CO−B−(AO)n−であ
り、他方がM2O−であり、M1およびM2はそれぞれ同
一または異なって、水素、アルカリ金属、アルカリ土類
金属、アンモニウム又はアルカノールアミンを表し、R
1は炭素数8〜22のアルキル基もしくはアルケニル
基、AOは炭素数2〜3のオキシアルキレン基、平均付
加モル数nは0〜20、Bは−NH−または炭素数2〜
3のモノアルカノールアミン残基を表す。]
項2 一般式(1)で示されるスルホコハク酸系界面活
性剤のAO基の平均付加モル数nが0〜7である項1記
載の口腔用組成物。
項3 一般式(1)で示されるスルホコハク酸系界面活
性剤のアルキル基もしくはアルケニル基の炭素数が10
〜14である項1記載の口腔用組成物。
項4 一般式(1)で示されるスルホコハク酸系界面活
性剤のM1およびM2がナトリウムである項1記載の口腔
用組成物。[Wherein one of X 1 and X 2 is R 1
O- (AO) n - or R 1 CO-B- (AO) n - is and the other is M 2 O-, M 1 and M 2 are the same or different and each is hydrogen, an alkali metal, alkaline earth Represents a metal, ammonium or alkanolamine, R
1 is an alkyl group or alkenyl group having 8 to 22 carbon atoms, AO is an oxyalkylene group having 2 to 3 carbon atoms, the average number of moles of addition n is 0 to 20, B is —NH— or 2 to 2 carbon atoms.
3 represents a monoalkanolamine residue of 3. Item 2 The oral composition according to Item 1, wherein the sulfosuccinic acid-based surfactant represented by the general formula (1) has an average number of added moles n of AO groups of 0 to 7. Item 3 The alkyl group or alkenyl group of the sulfosuccinic acid-based surfactant represented by the general formula (1) has 10 carbon atoms.
Item 14. The oral composition according to Item 1, which is -14. Item 4. The oral composition according to Item 1, wherein M 1 and M 2 of the sulfosuccinic acid-based surfactant represented by the general formula (1) are sodium.
【0008】なお、ステビオサイド、バニリン、アネト
ール及びベンジルサクシネートはそれらを含む植物抽出
液を配合してもかまわない。[0008] Stevioside, vanillin, anethole and benzyl succinate may be mixed with a plant extract containing them.
【0009】[0009]
【発明の実施の形態】本発明に用いるスルホコハク酸系
界面活性剤は、一般式(1)で表されるスルホコハク酸
モノエステルであれば、特に限定されるものではない。
一般式(1):BEST MODE FOR CARRYING OUT THE INVENTION The sulfosuccinic acid surfactant used in the present invention is not particularly limited as long as it is a sulfosuccinic acid monoester represented by the general formula (1). General formula (1):
【0010】[0010]
【化3】 [Chemical 3]
【0011】[式中、X1及びX2のいずれか一方がR1
O−(AO)n− 又はR1CO−B−(AO)n− であ
り、他方がM2O−であり、M1およびM2はそれぞれ同
一または異なって、水素、アルカリ金属、アルカリ土類
金属、アンモニウム又はアルカノールアミンを表し、R
1は炭素数8〜22のアルキル基もしくはアルケニル
基、AOは炭素数2〜3のオキシアルキレン基、平均付
加モル数nは0〜20、Bは−NH−または炭素数2〜
3のモノアルカノールアミン残基を表す。]
一般式(1)で表されるスルホコハク酸モノエステルに
おいて、R1は天然由来または合成した炭素数8〜22
程度の直鎖または分岐のアルキル基またはアルケニル基
である。例えば、ラウリル、ココイル、ミリスチル、ス
テアリル、C12〜C14合成アルキル、イソノニル、イソ
ドデシル、オクテニル、ドデケニルなどが挙げられる。
R1の炭素数が長いほど苦味や刺激は低減されるが、短
いほどステイン形成阻害効果が高くなるので、R1の炭
素数は10〜16程度が好ましく、12〜14程度がよ
り好ましい。特に、C12〜C14合成アルキルあるいはラ
ウリルとミリスチルを組合せて用いるのが最も好まし
い。[Wherein one of X 1 and X 2 is R 1
O- (AO) n - or R 1 CO-B- (AO) n - is and the other is M 2 O-, M 1 and M 2 are the same or different and each is hydrogen, an alkali metal, alkaline earth Represents a metal, ammonium or alkanolamine, R
1 is an alkyl group or alkenyl group having 8 to 22 carbon atoms, AO is an oxyalkylene group having 2 to 3 carbon atoms, the average number of moles of addition n is 0 to 20, B is —NH— or 2 to 2 carbon atoms.
3 represents a monoalkanolamine residue of 3. ] In the sulfosuccinic acid monoester represented by the general formula (1), R 1 is a naturally-occurring or synthesized carbon atom having 8 to 22 carbon atoms.
It is a straight-chain or branched alkyl group or alkenyl group to a degree. For example, lauryl, cocoyl, myristyl, stearyl, C 12 -C 14 synthetic alkyl, isononyl, isododecyl, octenyl, and the like Dodekeniru.
The longer the carbon number of R 1, the less bitterness and irritation, but the shorter the carbon number of R 1 , the higher the effect of inhibiting stain formation. Therefore, the carbon number of R 1 is preferably about 10 to 16, more preferably about 12 to 14. In particular, it is most preferable to use a combination of C 12 to C 14 synthetic alkyl or lauryl and myristyl.
【0012】M1及びM2は、それぞれ同一でも、異なっ
ていてもよく、水素、アルカリ金属、アルカリ土類金
属、アンモニウム又はアルカノールアミンである。アル
カリ金属としては、ナトリウム、カリウムなどが、アル
カリ土類金属としては、マグネシウムなどが、アルカノ
ールアミンとしては、モノエタノールアミン、ジエタノ
ールアミン、トリエタノールアミンなどが例示できる。
これらの中でも、M1及びM2としては、ナトリウムとマ
グネシウムがより好ましく、ナトリウムが特に好まし
い。M 1 and M 2, which may be the same or different, are hydrogen, alkali metal, alkaline earth metal, ammonium or alkanolamine. Examples of the alkali metal include sodium and potassium, examples of the alkaline earth metal include magnesium, and examples of the alkanolamine include monoethanolamine, diethanolamine, triethanolamine and the like.
Among these, as M 1 and M 2 , sodium and magnesium are more preferable, and sodium is particularly preferable.
【0013】AO基は、炭素数2〜3程度のオキシアル
キレン基であり、オキシエチレン基であることが好まし
い。AOの平均付加モル数nは、0〜20程度が好まし
い。平均付加モル数nは小さいほどステイン形成阻害効
果が高く、且つ苦味も低減されるので、nが0〜7程度
の場合が好ましく、0〜2程度が最も好ましい。ここ
に、平均付加モル数0とは、オキシアルキレンを付加し
ていないスルホコハク酸モノエステルを意味する。The AO group is an oxyalkylene group having about 2 to 3 carbon atoms, preferably an oxyethylene group. The average addition mole number n of AO is preferably about 0 to 20. The smaller the average added mole number n, the higher the effect of inhibiting stain formation and the less bitterness. Therefore, n is preferably about 0 to 7, most preferably about 0 to 2. Here, the average added mole number of 0 means a sulfosuccinic acid monoester to which oxyalkylene is not added.
【0014】一般式(1)で示されるスルホコハク酸モ
ノエステルの例としては、ポリオキシエチレン(7モ
ル)ラウリルスルホコハク酸2ナトリウム、ポリオキシ
エチレン(2モル)ラウリルスルホコハク酸2ナトリウ
ム、ポリオキシエチレン(1モル)ラウリルスルホコハ
ク酸2ナトリウム、ラウリルスルホコハク酸2ナトリウ
ム、ポリオキシエチレン(7モル)ミリスチルスルホコ
ハク酸2ナトリウム、ポリオキシエチレン(2モル)ア
ルキル(C12〜14)スルホコハク酸2ナトリウム、
ポリオキシエチレン(1モル)アルキル(C12〜1
4)スルホコハク酸2ナトリウム、アルキル(C12〜
14)スルホコハク酸2ナトリウム、ポリオキシエチレ
ン(2モル)ラウリルスルホコハク酸マグネシウム、ポ
リオキシエチレン(2モル)アルキル(C12〜14)
スルホコハク酸マグネシウム、ポリオキシエチレン(7
モル)ミリスチルスルホコハク酸2トリエタノールアミ
ンなどが挙げられる。一般式(2)で示される例として
は、オレイン酸アミドスルホコハク酸2ナトリウム、ポ
リオキシエチレン(5モル)ラウロイルエタノールアミ
ドスルホコハク酸2ナトリウム、ポリオキシエチレン
(2モル)ココイルイソプロパノールアミドスルホコハ
ク酸2ナトリウムなどが挙げられる。Examples of the sulfosuccinic acid monoester represented by the general formula (1) include polyoxyethylene (7 mol) disodium lauryl sulfosuccinate, polyoxyethylene (2 mol) disodium lauryl sulfosuccinate and polyoxyethylene ( 1 mol) disodium lauryl sulfosuccinate, disodium lauryl sulfosuccinate, polyoxyethylene (7 mol) disodium myristyl sulfosuccinate, polyoxyethylene (2 mol) alkyl (C12-14) disodium sulfosuccinate,
Polyoxyethylene (1 mol) alkyl (C12-1
4) Disodium sulfosuccinate, alkyl (C12-
14) Disodium sulfosuccinate, polyoxyethylene (2 mol) magnesium lauryl sulfosuccinate, polyoxyethylene (2 mol) alkyl (C12-14)
Magnesium sulfosuccinate, polyoxyethylene (7
Mol) myristyl sulfosuccinic acid 2 triethanolamine and the like. Examples of general formula (2) include oleic acid amide disodium sulfosuccinate, polyoxyethylene (5 mol) lauroylethanolamide disodium succinate, polyoxyethylene (2 mol) cocoylisopropanolamide disodium succinate, etc. Is mentioned.
【0015】また、最も好適なスルホコハク酸モノエス
テルは、一般式(1)において、R 1が炭素数12〜1
4程度のアルキル基で、AO基がオキシエチレン基であ
って、その平均付加モル数nが0〜2程度のナトリウム
塩である。具体的には、ポリオキシエチレン(2モル)
アルキル(C12〜14)スルホコハク酸2ナトリウ
ム、ポリオキシエチレン(1モル)アルキル(C12〜
14)スルホコハク酸2ナトリウム、アルキル(C12
〜14)スルホコハク酸2ナトリウムなどが挙げられ
る。Further, the most preferred sulfosuccinic acid monoeth
Tell is the same as R in the general formula (1). 1Has 12 to 1 carbon atoms
Alkyl group of about 4 and AO group is an oxyethylene group
So, the average addition mole number n is about 0-2
It is salt. Specifically, polyoxyethylene (2 mol)
Alkyl (C12-14) sulfosuccinic acid 2 sodium
, Polyoxyethylene (1 mol) alkyl (C12-
14) Disodium sulfosuccinate, alkyl (C12
~ 14) disodium sulfosuccinate and the like can be mentioned.
It
【0016】一般式(1)で表されるスルホコハク酸エ
ステルは、1種を単独で用いても2種以上を併用しても
よい。The sulfosuccinic acid ester represented by the general formula (1) may be used alone or in combination of two or more kinds.
【0017】一般式(1)で表されるスルホコハク酸モ
ノエステルの配合量は、通常、組成物全体に対しての
0.01〜5重量%程度が好ましく、さらに好ましくは
0.1〜2重量%程度である。配合量が0.01重量%
程度に満たないと十分なステイン形成阻害効果が得られ
ず、また5重量%程度を超えると使用感が悪くなってし
まう。The amount of the sulfosuccinic acid monoester represented by the general formula (1) is usually preferably about 0.01 to 5% by weight, more preferably 0.1 to 2% by weight, based on the whole composition. %. 0.01% by weight
If the amount is less than the above range, a sufficient stain formation inhibiting effect cannot be obtained, and if it exceeds about 5% by weight, the feeling of use becomes poor.
【0018】本発明に用いるステビオサイドは、単品化
合物として用いてもよいが、ステビオサイドを含有する
植物抽出液(例えばステビア抽出物)として配合しても
良い。The stevioside used in the present invention may be used as a single compound, or may be blended as a plant extract containing stevioside (eg stevia extract).
【0019】サッカリンナトリウムとステビオサイド
は、重量比で1:1〜8:1であって、合計量が組成物
全重量に対して0.01〜1重量%となるように配合す
る。サッカリンナトリウムもしくはステビオサイドのみ
では十分な苦味抑制効果が得られない。重量比が1:1
未満(ステビオサイド1重量部に対してサッカリンナト
リウム1重量部未満)、もしくは8:1を超える(ステ
ビオサイド1重量部に対してサッカリンナトリウムが8
重量部を超える)と十分な苦味改善効果がない。また、
その合計が0.01%未満であると十分な苦味抑制効果
が得られず、1%を超えると甘味が強すぎ使用感に問題
がある。Sodium saccharin and stevioside are mixed in a weight ratio of 1: 1 to 8: 1, and are added so that the total amount is 0.01 to 1% by weight based on the total weight of the composition. Saccharin sodium or stevioside alone cannot provide a sufficient bitterness suppressing effect. Weight ratio is 1: 1
Less than (1 part by weight of stevioside less than 1 part by weight of saccharin sodium) or more than 8: 1 (1 part by weight of stevioside contains 8 parts by weight of saccharin sodium).
When it exceeds the weight part), there is no sufficient bitterness improving effect. Also,
If the total is less than 0.01%, a sufficient bitterness-suppressing effect cannot be obtained, and if the total exceeds 1%, the sweetness is too strong and there is a problem in the feeling of use.
【0020】サッカリンナトリウムとステビオサイドの
好ましい配合割合は、1:1〜4:1程度である。ま
た、サッカリンナトリウムとステビオサイドの好ましい
配合量は、組成物全重量に対してサッカリンナトリウム
とステビオサイドの合計が0.02〜0.5重量%程度
となるように配合するのが好ましい。The preferred blending ratio of sodium saccharin and stevioside is about 1: 1 to 4: 1. Further, the preferable blending amount of saccharin sodium and stevioside is preferably such that the total amount of saccharin sodium and stevioside is about 0.02 to 0.5% by weight based on the total weight of the composition.
【0021】バニリン、アネトール、ベンジルサクシネ
ートに関しては、これらより選ばれる少なくとも1種を
配合すると、スルホコハク酸系界面活性剤の活性剤臭が
マスキングされる。バニリン、アネトール及びベンジル
サクシネートは単品化合物として用いてもよいが、これ
らを含有している精油などの植物抽出液として配合して
もよい。このような植物抽出物としては、バニリンを含
む精油としてバニラ油、丁子油などが挙げられ、アネト
ールを含む精油としてアニス油、スターアニス油、フェ
ンネル油などが挙げられ、ベンジルサクシネートを含む
精油としてクランベリー油などが挙げられる。With respect to vanillin, anethole, and benzyl succinate, when at least one selected from these is blended, the odor of the active agent of the sulfosuccinic acid type surfactant is masked. Although vanillin, anethole, and benzyl succinate may be used as a single compound, they may be mixed as a plant extract containing essential oils containing them. Examples of such plant extracts include vanilla oil and clove oil as essential oils containing vanillin, anise oil as essential oils containing anethole, star anise oil, fennel oil and the like, and essential oils containing benzyl succinate. Examples include cranberry oil.
【0022】バニリン、アネトール及びベンジルサクシ
ネートの少なくとも1種の配合量は、組成物全体に対し
て、通常、0.0001〜1重量%程度、好ましくは
0.001〜0.5重量%程度、より好ましくは0.0
01〜0.2重量%程度である。The blending amount of at least one of vanillin, anethole and benzyl succinate is usually about 0.0001 to 1% by weight, preferably about 0.001 to 0.5% by weight, based on the whole composition. More preferably 0.0
It is about 01 to 0.2% by weight.
【0023】本発明のステイン形成阻害用口腔用組成物
は、常法により粉歯磨、練歯磨、ジェル、プリフィーペ
ースト、パスタ、液体歯磨、洗口剤、チューイングガ
ム、デンタルフロス、貼付剤、シーラント、タブレット
などの剤形にできるが、使用性から歯磨剤、液体歯磨、
あるいは洗口剤が特に好ましい。The oral composition for inhibiting stain formation of the present invention comprises a powder toothpaste, a toothpaste, a gel, a pre-paste, a pasta, a liquid toothpaste, a mouthwash, a chewing gum, a dental floss, a patch, a sealant, and Although it can be made into a dosage form such as a tablet, dentifrice, liquid dentifrice,
Alternatively, a mouthwash is particularly preferable.
【0024】本発明の口腔用組成物では、スルホコハク
酸系界面活性剤、サッカリン、ステビオサイド、バニリ
ン、アネトール、ベンジルサクシネートに加えて、水、
低級アルコール、高級アルコール、当該分野において通
常使用される添加剤を、剤形などに応じて適宜配合する
ことができる。このような添加剤としては、研磨剤、賦
形剤、発泡剤、バニリン、アネトール及びベンジルサク
シネート以外の香料、サッカリン及びステビオサイド以
外の甘味剤、粘結剤、pH調製剤、湿潤剤、防腐剤、着
色剤、各種薬効成分などを、発明の効果を損なわない範
囲で配合することができる。In the oral composition of the present invention, in addition to the sulfosuccinic acid type surfactant, saccharin, stevioside, vanillin, anethole and benzyl succinate, water,
Lower alcohols, higher alcohols and additives usually used in the art can be appropriately blended depending on the dosage form and the like. Examples of such additives include abrasives, excipients, foaming agents, fragrances other than vanillin, anethole and benzyl succinate, sweeteners other than saccharin and stevioside, binders, pH adjusters, wetting agents, preservatives. , A colorant, various medicinal components and the like can be added within a range that does not impair the effects of the invention.
【0025】水の配合量は、剤形などに応じて適宜設定
することができるが、組成物全体に対して、通常0〜90
重量%程度、好ましくは10〜85%程度である。低級アル
コールの配合量は、組成物全体に対して、通常0〜20重
量%程度、好ましくは0〜10%程度である。高級アルコー
ルの配合量は、組成物全体に対して、通常0〜70重量%
程度、好ましくは5〜50%程度である。The amount of water to be added can be appropriately set depending on the dosage form and the like, but is usually 0 to 90 relative to the whole composition.
It is about% by weight, preferably about 10 to 85%. The amount of the lower alcohol compounded is usually about 0 to 20% by weight, preferably about 0 to 10%, based on the entire composition. The amount of higher alcohol is usually 0 to 70% by weight based on the whole composition.
The degree is about 5 to 50%.
【0026】例えば、歯磨剤では、研磨剤として、第2
リン酸カルシウム・2水和物および無水和物、リン酸カ
ルシウム、第3リン酸カルシウム、炭酸カルシウム、ピ
ロリン酸カルシウム、水酸化アルミニウム、アルミナ、
シリカゲル、ケイ酸アルミニウム、沈降性シリカ、不溶
性メタリン酸ナトリウム、第3リン酸マグネシウム、炭
酸マグネシウム、硫酸カルシウム、ポリメタクリル酸メ
チル、ベントナイト、ケイ酸ジルコニウム、ハイドロキ
シアパタイト、合成樹脂などを用いることができる。こ
れらの研磨剤は単独で用いても2種以上を併用してもよ
く、その配合量は、組成物全重量に対して、通常5〜9
0重量%程度、練歯磨の場合には5〜50重量%程度で
ある。For example, in a dentifrice, a second abrasive is used as an abrasive.
Calcium phosphate dihydrate and anhydrate, calcium phosphate, tertiary calcium phosphate, calcium carbonate, calcium pyrophosphate, aluminum hydroxide, alumina,
Silica gel, aluminum silicate, precipitable silica, insoluble sodium metaphosphate, tribasic magnesium phosphate, magnesium carbonate, calcium sulfate, polymethyl methacrylate, bentonite, zirconium silicate, hydroxyapatite, synthetic resin and the like can be used. These abrasives may be used alone or in combination of two or more, and the compounding amount thereof is usually 5 to 9 relative to the total weight of the composition.
It is about 0% by weight, and in the case of toothpaste, it is about 5 to 50% by weight.
【0027】賦形剤として、例えば、火成性シリカ、増
粘性シリカ(一般に、RDA値が30以下程度のシリカを
示す)、結晶セルロースを含む粉体状セルロースなどを
例示することができる。これらの中では、火成性シリ
カ、増粘性シリカが好ましい。賦形剤の配合量は、組成
物全重量に対して、通常0.1〜30重量%程度であり、好
ましくは0.5〜10重量%程度である。Examples of the excipient include ignitable silica, thickening silica (generally, silica having an RDA value of about 30 or less), powdery cellulose containing crystalline cellulose and the like. Of these, pyrogenic silica and thickening silica are preferable. The amount of the excipient to be added is usually about 0.1 to 30% by weight, preferably about 0.5 to 10% by weight, based on the total weight of the composition.
【0028】発泡剤としては、一般式(1)で表されるス
ルホコハク酸系界面活性剤以外のアニオン性界面活性剤
が挙げられる。例えば、ラウリル硫酸ナトリウム、ミリ
スチル硫酸ナトリウム等のアルキル基の炭素数が8〜1
8である高級アルキル硫酸エステル塩;N−長鎖アシル
アミノ酸塩、α−オレフィンスルホネート塩、高級脂肪
酸ナトリウムモノグリセライドモノサルフェート、N−
メチル−N−パルミトイルタウライド塩、N−アシルサ
ルコシンナトリウム、N−アシルグルタミン酸塩、N−
メチル−N−アシルタウリンナトリウム、N−メチル−
N−アシルアラニンナトリウム、α−オレフィンスルホ
ン酸ナトリウムなどのアニオン性界面活性剤などを例示
することができる。これらアニオン性界面活性剤には化
学的溶解によるステイン除去作用の高いものが多く、特
にラウリル硫酸ナトリウムを配合するとステイン形成抑
制効果が相乗的に高くなるので好ましい。これらのアニ
オン性界面活性剤は単独で用いても2種以上を併用して
もよい。一般式(1)で表されるスルホコハク酸系界面活
性剤以外のアニオン性界面活性剤の配合量は、通常、組
成物全体に対して0.001〜5重量%程度、好ましく
は0.01〜2重量%程度である。Examples of the foaming agent include anionic surfactants other than the sulfosuccinic acid type surfactant represented by the general formula (1). For example, the number of carbon atoms of the alkyl group such as sodium lauryl sulfate and sodium myristyl sulfate is 8 to 1.
8 higher alkyl sulfate ester salt; N-long chain acyl amino acid salt, α-olefin sulfonate salt, higher fatty acid sodium monoglyceride monosulfate, N-
Methyl-N-palmitoilide salt, N-acyl sarcosine sodium, N-acyl glutamate, N-
Methyl-N-acyl taurine sodium, N-methyl-
Anionic surfactants such as sodium N-acylalanine and sodium α-olefinsulfonate can be exemplified. Many of these anionic surfactants have a high stain-removing effect by chemical dissolution, and it is particularly preferable to add sodium lauryl sulfate because the stain formation-inhibiting effect is synergistically enhanced. These anionic surfactants may be used alone or in combination of two or more kinds. The amount of the anionic surfactant other than the sulfosuccinic acid-based surfactant represented by the general formula (1) is usually about 0.001 to 5% by weight, preferably 0.01 to 5% by weight based on the whole composition. It is about 2% by weight.
【0029】また、アニオン界面活性剤以外にも、通常
口腔用組成物に用いられる両性界面活性剤、カチオン性
界面活性剤や非イオン性界面活性剤を配合してもよい。
この様な界面活性剤としては、例えば、ポリオキシエチ
レンソルビタンモノラウレート等のポリオキシエチレン
ソルビタン脂肪酸エステル等のポリオキシエチレン脂肪
酸エステル、ポリオキシエチレン硬化ヒマシ油、ラウリ
ン酸モノエタノールアミド、ミリスチン酸モノエタノー
ルアミド、ポリオキシエチレン高級アルコールエーテ
ル、ポリオキシエチレンポリオキシプロピレン共重合
体、ポリオキシエチレンポリオキシプロピレン脂肪酸エ
ステルアルキルグリコシド(例えばアルキル鎖:C8〜
C16程度)、ポリグリセリン脂肪酸エステル(例えば脂
肪酸部分のアルキル鎖:C8〜C16程度)、ショ糖脂
肪酸エステル(例えば脂肪酸部分のアルキル鎖:C8〜
C16程度)等の非イオン性界面活性剤;N−アルキル
ジアミノエチルグリシン、アルキルベタイン、脂肪酸ア
ミドプロピルベタイン(例えば脂肪酸部分のアルキル
鎖:C8〜C16程度)、アルキルスルホベタイン、ア
ルキルベタインイミダゾニウムベタインなどの両性界面
活性剤;塩化アルキルトリメチルアンモニウム、臭化ア
ルキルトリメチルアンモニウム、塩化アルキルジメチル
アンモニウムなどのカチオン性界面活性剤などを例示す
ることができる。これらの中では、ポリオキシエチレン
硬化ヒマシ油、アルキルグリコシドが好ましい。In addition to the anionic surfactant, an amphoteric surfactant, a cationic surfactant or a nonionic surfactant usually used in oral compositions may be added.
Examples of such surfactants include polyoxyethylene sorbitan monolaurate and other polyoxyethylene sorbitan fatty acid esters such as polyoxyethylene fatty acid esters, polyoxyethylene hydrogenated castor oil, lauric acid monoethanolamide, myristic acid monoester. Ethanolamide, polyoxyethylene higher alcohol ether, polyoxyethylene polyoxypropylene copolymer, polyoxyethylene polyoxypropylene fatty acid ester alkyl glycoside (for example, alkyl chain: C8-
C16), polyglycerin fatty acid ester (for example, fatty acid part alkyl chain: C8 to C16), sucrose fatty acid ester (for example, fatty acid part alkyl chain: C8-
Nonionic surfactants such as C16) and the like; N-alkyldiaminoethylglycine, alkylbetaine, fatty acid amidopropylbetaine (for example, alkyl chain of fatty acid part: C8 to C16), alkylsulfobetaine, alkylbetaine imidazolium betaine, etc. And amphoteric surfactants such as: alkyl trimethyl ammonium chloride, alkyl trimethyl ammonium bromide, alkyl dimethyl ammonium chloride, and other cationic surfactants. Of these, polyoxyethylene hydrogenated castor oil and alkyl glycosides are preferable.
【0030】一般式(1)で示されるスルホコハク酸系界
面活性剤とアニオン性界面活性剤を除いた界面活性剤の
配合量は、通常組成物全体に対して0.001〜5重量
%程度、好ましくは0.01〜2重量%程度である。The amount of the sulfosuccinic acid-based surfactant represented by the general formula (1) and the surfactant excluding the anionic surfactant is usually about 0.001 to 5% by weight based on the whole composition, It is preferably about 0.01 to 2% by weight.
【0031】粘結剤としては、カルボキシメチルセルロ
ースナトリウムなどのセルロース誘導体;アルギン酸ナ
トリウムなどのアルカリ金属アルギネート;アルギン酸
プロピレングリコールエステル、キサンタンガム、トラ
ガカントガム、カラヤガム、アラビアガム、カラギーナ
ンなどのガム類;ポリビニルアルコール、ポリアクリル
酸ナトリウム、カルボキシビニルポリマー、ポリビニル
ピロリドンなどの合成粘結剤などが挙げられる。粘結剤
は、単独で用いても2種以上を併用してもよい。その配
合量は、通常、組成物全体に対して0.3〜5重量%程
度である。Examples of the binder include cellulose derivatives such as sodium carboxymethyl cellulose; alkali metal alginates such as sodium alginate; gums such as propylene glycol alginate ester, xanthan gum, tragacanth gum, karaya gum, gum arabic, and carrageenan; polyvinyl alcohol, polyacryl. Examples thereof include synthetic binders such as sodium acidate, carboxyvinyl polymer, and polyvinylpyrrolidone. The binder may be used alone or in combination of two or more kinds. The compounding amount thereof is usually about 0.3 to 5% by weight based on the whole composition.
【0032】バニリン、アネトール及びベンジルサクシ
ネート以外の香料としては、メントール、カルボン、オ
イゲノール、サリチル酸メチル、リモネン、オシメン、
n−デシルアルコール、シトロネロール、α−テルピネ
オール、メチルアセテート、シトロネリルアセテート、
メチルオイゲノール、シオネール、リナロール、エチル
リナロール、ワニリン、チモールなどが挙げられる。こ
れらは、単品化合物として用いてもよいが、これらを含
有している精油などの植物抽出液として配合してもよ
い。また、香料としては、タイム油、ナツメグ油、スペ
アミント油、ペパーミント油、レモン油、オレンジ油、
セージ油、ローズマリー油、桂皮油、ピメント油、珪藻
油、シソ油、冬緑油、ユーカリ油、バジル油、ティーツ
リー油、タバナ油などが挙げられる。香料は単独で用い
ても2種以上を併用してもよい。バニリン、アネトール
及びベンジルサクシネート以外の香料の配合量は、通
常、組成物全体に対して0.05〜10重量%程度、好
ましくは0.1〜5重量%程度である。Fragrances other than vanillin, anethole and benzyl succinate include menthol, carvone, eugenol, methyl salicylate, limonene, ocimene,
n-decyl alcohol, citronellol, α-terpineol, methyl acetate, citronellyl acetate,
Examples thereof include methyl eugenol, sionel, linalool, ethyl linalool, vanillin and thymol. These may be used as a single compound, but may also be blended as a plant extract liquid such as an essential oil containing them. Also, as fragrances, thyme oil, nutmeg oil, spearmint oil, peppermint oil, lemon oil, orange oil,
Examples include sage oil, rosemary oil, cinnamon oil, pimento oil, diatom oil, perilla oil, wintergreen oil, eucalyptus oil, basil oil, tea tree oil, and tabana oil. The fragrances may be used alone or in combination of two or more. The blending amount of the fragrance other than vanillin, anethole and benzyl succinate is usually about 0.05 to 10% by weight, preferably about 0.1 to 5% by weight, based on the entire composition.
【0033】サッカリンナトリウム及びステビオサイド
以外の甘味剤としては、アセスルファームK、グリチル
リチン、ペリラルチン、タウマチン、アスパルチルフェ
ニルアラニンメチルエステル、キシリトール、パラチノ
ース、パラチニット、エリスリトール、マルチトールな
どの甘味剤が挙げられる。甘味剤は、単独で用いても2
種以上を併用してもよい。サッカリンナトリウム及びス
テビオサイド以外の甘味剤の配合量は、通常、組成物全
体に対して0.01〜5重量%程度である。Examples of sweeteners other than sodium saccharin and stevioside include sweeteners such as acesulfame K, glycyrrhizin, perillartin, taumatine, aspartylphenylalanine methyl ester, xylitol, palatinose, palatinit, erythritol and maltitol. The sweetener can be used alone or 2
You may use together 1 or more types. The amount of the sweetening agent other than sodium saccharin and stevioside is usually about 0.01 to 5% by weight based on the entire composition.
【0034】湿潤剤としては、例えば、ソルビット液、
グリセリン、エチレングリコール、プロピレングリコー
ル、1,3−ブチレングリコール、ポリエチレングリコ
ール、ポリプロピレングリコール、ラクチット等が挙げ
られる。湿潤剤は、単独で用いても2種以上を併用して
もよく、その配合量は、通常、組成物全体に対して5〜
70重量%程度である。As the wetting agent, for example, sorbit solution,
Examples thereof include glycerin, ethylene glycol, propylene glycol, 1,3-butylene glycol, polyethylene glycol, polypropylene glycol and lactit. The wetting agent may be used alone or in combination of two or more kinds, and the compounding amount thereof is usually 5 to the whole composition.
It is about 70% by weight.
【0035】pH調整剤としては、例えば、リン酸および
その塩(リン酸ナトリウム、リン酸水素ナトリウムな
ど)、クエン酸およびその塩(ナトリウム等)、リン酸お
よびその塩、リンゴ酸およびその塩、グルコン酸および
その塩、マレイン酸およびその塩、アスパラギン酸およ
びその塩、グルコン酸およびその塩、コハク酸およびそ
の塩、グルクロン酸およびその塩、フマル酸およびその
塩、グルタミン酸およびその塩、アジピン酸およびその
塩、塩酸、水酸化ナトリウム、水酸化カリウム、ケイ酸
ナトリウムなどを例示することができる。pH調整剤は、
単独で用いても2種以上を併用してもよい。pH調整剤の
配合量は、所望のpHとなる限り特に制限されないが、組
成物全体に対して、通常0.01〜5重量%程度、好ましく
は0.1〜3重量%程度である。本発明の組成物のpHは、本
発明の効果が奏される限り特に制限されないが、通常4
〜10程度であり、好ましくは5.5〜9程度である。Examples of the pH adjuster include phosphoric acid and its salts (sodium phosphate, sodium hydrogen phosphate, etc.), citric acid and its salts (sodium, etc.), phosphoric acid and its salts, malic acid and its salts, Gluconic acid and its salts, maleic acid and its salts, aspartic acid and its salts, gluconic acid and its salts, succinic acid and its salts, glucuronic acid and its salts, fumaric acid and its salts, glutamic acid and its salts, adipic acid and Examples thereof include salts thereof, hydrochloric acid, sodium hydroxide, potassium hydroxide, sodium silicate and the like. The pH adjuster is
They may be used alone or in combination of two or more. The compounding amount of the pH adjuster is not particularly limited as long as it has a desired pH, but is usually about 0.01 to 5% by weight, preferably about 0.1 to 3% by weight, based on the entire composition. The pH of the composition of the present invention is not particularly limited as long as the effects of the present invention are exhibited, but is usually 4
It is about 10 and preferably about 5.5-9.
【0036】防腐剤としては、安息香酸ナトリウムなど
の安息香酸塩;メチルパラベン、ブチルパラベンなどの
パラベン類を例示することができる。防腐剤は、単独で
用いても2種以上を併用してもよい。防腐剤の配合量
は、組成物全体に対して、通常0.01〜3重量%程度であ
る。Examples of preservatives include benzoates such as sodium benzoate; parabens such as methylparaben and butylparaben. The preservatives may be used alone or in combination of two or more. The content of the preservative is usually about 0.01 to 3% by weight based on the whole composition.
【0037】着色剤としては、例えば、青色1号、黄色
4号、赤色202号、緑3号などの法定色素;群青、強
化群青、紺青などの鉱物系色素;酸化チタンなどを例示
することができる。着色剤は、単独で用いても2種以上
を併用してもよい。着色剤の配合量は、組成物全体に対
して、通常0.0001〜1重量%程度である。Examples of the colorant include legal dyes such as Blue No. 1, Yellow No. 4, Red No. 202 and Green No. 3; mineral dyes such as ultramarine blue, reinforced ultramarine blue and dark blue; titanium oxide and the like. it can. The colorants may be used alone or in combination of two or more. The amount of the colorant compounded is usually about 0.0001 to 1% by weight based on the entire composition.
【0038】薬効成分としては、例えば、塩化セチルピ
リジニウム、塩化ベンゼトニウム、塩化ジステアリルジ
メチルアンモニウム、塩化ステアリルジメチルベンジル
アンモニウム、塩化ステアリルトリメチルアンモニウ
ム、塩化ラウリルトリメチルアンモニウム、塩化ラウリ
ルピリジニウム等の第四級アンモニウム塩、塩酸クロル
ヘキシジン、酢酸クロルヘキシジン、グルコン酸クロル
ヘキシジン、塩酸アレキシジン、酢酸アレキシジン、グ
ルコン酸アレキシジン等のビグアニド系殺菌剤等のカチ
オン性殺菌剤;n−ラウロイルサルコンシンナトリウム
などのアニオン性殺菌剤;トリクロサン、イソプロピル
メチルフェノール等の非イオン性殺菌剤;デキストラナ
ーゼ、アミラ−ゼ、パパイン、プロテアーゼ、ムタナー
ゼ、リゾチーム、溶菌酵素(リテックエンザイム)など
の酵素;酸化亜鉛、塩化亜鉛などの亜鉛化合物;モノフ
ルオロリン酸ナトリウム、モノフルオロリン酸カリウム
などのアルカリ金属モノフルオロホスフェート、フッ化
ナトリウム、フッ化第一スズなどのフッ化物、トラネキ
サム酸、イプシロンアミノカプロン酸、アルミニウムク
ロルヒドロキシルアラントイン、ジヒドロコレステロー
ル、酢酸トコフェロールなどのビタミンE誘導体、グリ
チルリチン塩類、グリチルレチン酸、グリセロホスフェ
ート、クロロフィル、硝酸カリウム、塩化ナトリウム、
カロペプタイド、水溶性無機リン酸化合物などが挙げら
れる。Examples of the medicinal component include quaternary ammonium salts such as cetylpyridinium chloride, benzethonium chloride, distearyldimethylammonium chloride, stearyldimethylbenzylammonium chloride, stearyltrimethylammonium chloride, lauryltrimethylammonium chloride and laurylpyridinium chloride, Cationic fungicides such as biguanide fungicides such as chlorhexidine hydrochloride, chlorhexidine acetate, chlorhexidine gluconate, alexidine hydrochloride, alexidine acetate and alexidine gluconate; anionic bactericides such as sodium n-lauroyl sarconcin; triclosan, isopropylmethylphenol Non-ionic fungicides such as dextranase, amylase, papain, protease, mutanase, lysozyme, lysate Enzymes such as enzymes (Litech Enzyme); zinc compounds such as zinc oxide and zinc chloride; alkali metal monofluorophosphates such as sodium monofluorophosphate and potassium monofluorophosphate; fluorine such as sodium fluoride and stannous fluoride. Compounds, tranexamic acid, epsilon aminocaproic acid, aluminum chlorhydroxyl allantoin, dihydrocholesterol, vitamin E derivatives such as tocopherol acetate, glycyrrhizin salts, glycyrrhetinic acid, glycerophosphate, chlorophyll, potassium nitrate, sodium chloride,
Caropeptides, water-soluble inorganic phosphate compounds and the like can be mentioned.
【0039】水溶性無機リン酸化合物としては、
一般式(2):
Mm+2PmO3m+1
[式中、Mは、NaまたはKを示し、mは2以上の整数
である。]
一般式(3):
(MPO3)l
[式中、Mは、NaまたはKを示し、lは3以上の整数
である。]
で表される化合物が例示される。The water-soluble inorganic phosphoric acid compound is represented by the general formula (2): M m + 2 P m O 3m + 1 [wherein M represents Na or K, and m is an integer of 2 or more]. General formula (3): (MPO 3 ) l [In the formula, M represents Na or K, and l is an integer of 3 or more. ] The compound represented by these is illustrated.
【0040】mは、通常2以上の整数であり、好ましく
は2〜6程度の整数である。lは、通常3以上の整数であ
り、好ましくは3〜6程度の整数である。M is usually an integer of 2 or more, preferably about 2 to 6. l is usually an integer of 3 or more, preferably about 3 to 6.
【0041】式(2)で示される化合物の具体例とし
て、ピロリン酸ナトリウム、ピロリン酸カリウム、トリ
ポリリン酸ナトリウムなどを挙げることができる。Specific examples of the compound represented by the formula (2) include sodium pyrophosphate, potassium pyrophosphate, sodium tripolyphosphate and the like.
【0042】式(3)で示される化合物の具体例として
は、例えば、テトラメタリン酸ナトリウム、ヘキサメタ
リン酸ナトリウムなどを挙げることができる。Specific examples of the compound represented by the formula (3) include sodium tetrametaphosphate and sodium hexametaphosphate.
【0043】有効成分は、単独で用いても2種以上を併
用してもよい。有効成分の配合量は、所望の効果が得ら
れる範囲内であれば特に制限されず、有効成分の種類な
どに応じて適宜設定することができる。有効成分の配合
量は、組成物全体に対して、通常0.001〜30重量%程
度、好ましくは0.01〜20重量%程度である。The active ingredients may be used alone or in combination of two or more kinds. The compounding amount of the active ingredient is not particularly limited as long as it is within a range in which a desired effect is obtained, and can be appropriately set according to the kind of the active ingredient. The content of the active ingredient is usually about 0.001 to 30% by weight, preferably about 0.01 to 20% by weight, based on the entire composition.
【0044】[0044]
【実施例】以下、実施例を挙げて本発明をさらに詳しく
説明するが、本発明はこれらに限定されるものではな
い。また、特に断らない限り、[%]は[重量%]を示
す。The present invention will be described in more detail below with reference to examples, but the present invention is not limited thereto. In addition, unless otherwise specified, [%] indicates [% by weight].
【0045】下記に示す成分を配合し、常法に従って練
歯磨を調製し、評価に用いた。The components shown below were blended and a toothpaste was prepared according to a conventional method and used for evaluation.
【0046】実施例1〜4及び比較例1〜4
処方
成分
増粘性シリカ 5.0
沈降性シリカ 18.0
ソルビット液(70%) 35.0
スルホコハク酸系界面活性剤 表1に示す
サッカリンナトリウム 表1に示す
ステビオサイド 表1に示す
トリクロサン 0.1
カルボキシメチルセルロールナトリウム 1.0
バニリン 表1に示す
アネトール 表1に示す
ベンジルサクシネート 表1に示す
香料 0.9水 残部
計 100.0
評価方法
(苦みの評価)苦味の評価は、被験歯磨剤で歯を磨いた
ときの苦味の程度を5点満点で評価した。1点:活性剤
臭を感じない、2点:ほとんど活性剤臭を感じない、3
点:活性剤臭を少し感じる、4点:活性剤臭を感じる、
5点:非常に強く活性剤臭を感じる。 Examples 1 to 4 and Comparative Examples 1 to 4 Formulation components Thickening silica 5.0 Precipitating silica 18.0 Solbit solution (70%) 35.0 Sulfosuccinic acid type surfactant Saccharin sodium shown in Table 1 Stevioside as shown in Table 1 Triclosan 0.1 Carboxymethylcellulose sodium 1.0 Vanillin as shown in Table 1 Anethole as shown in Table 1 Benzyl succinate as shown in Table 1 Perfume 0.9 as shown in Table 1 Water balance 100.0 Evaluation method (bitterness The evaluation of bitterness was carried out by evaluating the degree of bitterness when brushing teeth with the test dentifrice on a scale of 5 points. 1 point: No activator odor is felt, 2 points: Almost no activator odor is felt, 3
Point: Slight activator odor, 4 point: Activator odor,
5 points: Very strong odor of the active agent is felt.
【0047】5名のパネラーの評価点を加算し、5点以
上10点以下を○、11点以上15点以下△、16点以
上を×とした。点数が高いほど苦味が強いことを示す。
(活性剤臭の評価)活性剤臭の評価は、被験歯磨剤で歯
を磨いたときの臭みの程度を5点満点で評価した。1
点:活性剤臭を感じない、2点:ほとんど活性剤臭を感
じない、3点:活性剤臭を少し感じる、4点:活性剤臭
を感じる、5点:非常に強く活性剤臭を感じる。Evaluation points of 5 panelists were added, and 5 points or more and 10 points or less were evaluated as O, 11 points or more and 15 points or less Δ, and 16 points or more were evaluated as X. The higher the score, the stronger the bitterness. (Evaluation of Active Agent Odor) The evaluation of the active agent odor was made by evaluating the degree of odor when brushing teeth with the test dentifrice on a scale of 5 points. 1
Points: No active agent odor is felt, 2 points: Almost no active agent odor is felt, 3 points: A little active agent odor is felt, 4 points: Active agent odor is felt, 5 points: Active agent odor is felt very strongly. .
【0048】5名のパネラーの評価点を加算し、5点以
上10点以下を○、11点以上15点以下△、16点以
上を×とした。点数が高いほど活性剤臭が強いことを示
す。Evaluation points of 5 panelists were added, and 5 points or more and 10 points or less were evaluated as O, 11 points or more and 15 points or less Δ, and 16 points or more were evaluated as X. The higher the score, the stronger the activator odor.
【0049】これらの評価結果を、表1に示す。The results of these evaluations are shown in Table 1.
【0050】[0050]
【表1】 [Table 1]
【0051】表1に示すように、サッカリンナトリウム
とステビアエキスを1:1〜8:1の重量比で0.01
%以上1%未満で配合し、さらにバニリン、アネトー
ル、ベンジルサクシネートから選択される1種または2
種以上の香料化合物を配合した場合は苦味が少なく、活
性剤臭も少なかった。また、実施例1〜4のいずれの歯
磨剤も、ステイン形成の阻害が認められた。As shown in Table 1, sodium saccharin and stevia extract were mixed in a weight ratio of 1: 1 to 8: 1 of 0.01.
% Or more and less than 1%, and one or two selected from vanillin, anethole and benzyl succinate.
When more than one flavor compound was added, the bitterness was low and the active agent odor was low. In addition, inhibition of stain formation was observed in all of the dentifrices of Examples 1 to 4.
【0052】実施例5 次の処方により、常法に従って練歯磨を調製した。 成分 配合量(%) 炭酸カルシウム 30.0 増粘性シリカ 3.0 ソルビット液(70%) 30.0 カルボキシメチルセルロースナトリウム 1.0 ラウリル硫酸ナトリウム 1.2 ラウリルスルホコハク酸2ナトリウム 2.0 n−ラウロイルサルコシンナトリウム 0.1 香料 0.9 バニラ油(バニリン含有) 0.01 アネトール 0.05 ベンジルサクシネート 0.01 サッカリンナトリウム 0.2 ステビアエキス(ステビオサイド70%配合) 0.04 水 残部 計 100.0Example 5 A toothpaste was prepared according to a conventional method according to the following formulation. Ingredient amount (%) Calcium carbonate 30.0 Thickening silica 3.0 Sorbit solution (70%) 30.0 Carboxymethyl cellulose sodium 1.0 Sodium lauryl sulfate 1.2 Disodium lauryl sulfosuccinate 2.0 n-Lauroyl sarcosine sodium 0.1 Fragrance 0.9 Vanilla oil (containing vanillin) 0.01 Anethole 0.05 Benzyl succinate 0.01 Saccharin sodium 0.2 Stevia extract (70% Stevioside) 0.04 Remaining water 100.0 in total
【0053】実施例6 次の処方により、常法に従って練歯磨を調製した。 成分 配合量(%) 増粘性シリカ 5.0 沈降性シリカ 15.0 ソルビット液(70%) 30.0 グリセリン 10.0 酸化チタン 0.5 ポリエチレングリコール400 3.0 カルボキシメチルセルロースナトリウム 1.0 ラウリル硫酸ナトリウム 1.0 ポリオキシエチレン(60)硬化ヒマシ油 1.0 ポリオキシエチレン(2モル)アルキル (12〜14)スルホコハク酸2ナトリウム 1.0 フッ化ナトリウム 0.2 イソプロピルメチルフェノール 0.05 香料 0.9 バニリン 0.02 スターアニス油(アネトール含有) 0.03 サッカリンナトリウム 0.2 ステビアエキス(ステビオサイド50%) 0.1 水 残部 計 100.0Example 6 A toothpaste was prepared according to a conventional method according to the following formulation. Ingredient amount (%) Thickening silica 5.0 Precipitating silica 15.0 Sorbit solution (70%) 30.0 Glycerin 10.0 Titanium oxide 0.5 Polyethylene glycol 400 3.0 Carboxymethyl cellulose sodium 1.0 Sodium lauryl sulfate 1.0 Polyoxyethylene (60) hydrogenated castor oil 1.0 Polyoxyethylene (2 mol) alkyl (12-14) Disodium sulfosuccinate 1.0 Sodium fluoride 0.2 Isopropyl methylphenol 0.05 Fragrance 0.9 Vanillin 0.02 Star anise oil (containing anethole) 0.03 Saccharin sodium 0.2 Stevia extract (Stebioside 50%) 0.1 Remaining water 100.0 in total
【0054】実施例7 次の処方により、常法に従って洗口剤を調製した。 成分 配合量(%) グリセリン 10.0 エタノール 8.0 ポリオキシエチレン(60)硬化ヒマシ油 0.5 香料 0.3 バニリン 0.01 ベンジルサクシネート 0.01 サッカリンナトリウム 0.03 ステビオサイド 0.01 ポリオキシエチレン(1モル)ラウリル スルホコハク酸2ナトリウム 0.3 水 残部 計 100.0Example 7 A mouthwash was prepared according to a conventional method according to the following formulation. Ingredient amount (%) Glycerin 10.0 Ethanol 8.0 Polyoxyethylene (60) hydrogenated castor oil 0.5 Fragrance 0.3 Vanillin 0.01 Benzyl succinate 0.01 Saccharin sodium 0.03 Stevioside 0.01 Polyoxyethylene (1 mol) lauryl Disodium sulfosuccinate 0.3 Remaining water 100.0 in total
【0055】実施例8
次の処方により、常法に従って液体歯磨を調製した。
成分 配合量(%)
グリセリン 10.0
エタノール 7.0
ポリオキシエチレン(60)硬化ヒマシ油 0.5
プロピレングリコール 5.0
ポリエチレングリコール 1.0
香料 0.2
フェンネル油(アネトール含有) 0.01
サッカリンナトリウム 0.1
ステビオサイド 0.02
ラウリルスルホコハク酸2ナトリウム 0.4
塩化セチルピリジニウム 0.02
水 残部
計 100.0
以上実施例5、6、7及び8により調製した口腔用組成
物においても、ステイン形成の阻害が認められ、さらに
苦味と活性剤臭の抑制が認められた。Example 8 A liquid dentifrice was prepared according to a conventional method according to the following formulation. Ingredients Amount (%) Glycerin 10.0 Ethanol 7.0 Polyoxyethylene (60) Hydrogenated castor oil 0.5 Propylene glycol 5.0 Polyethylene glycol 1.0 Perfume 0.2 Fennel oil (containing anethole) 0.01 Saccharin sodium 0.1 Stevioside 0.02 Disodium lauryl sulfosuccinate 0.4 Cetylpyridinium chloride 0.02 Water balance 100.0 The oral compositions prepared according to Examples 5, 6, 7 and 8 also showed stain formation. Inhibition was observed, and further suppression of bitterness and active agent odor was observed.
【0056】[0056]
【発明の効果】本発明によれば、ステイン形成を効果的
に阻害しすることで審美的に優れた歯牙を維持でき、さ
らに苦味や活性剤臭のない使用感に優れた口腔用組成物
が提供できる。EFFECTS OF THE INVENTION According to the present invention, there is provided an oral composition capable of maintaining an aesthetically excellent tooth by effectively inhibiting stain formation and having an excellent feeling of use without bitterness or active agent odor. Can be provided.
フロントページの続き Fターム(参考) 4C083 AA122 AB172 AB242 AB472 AC102 AC122 AC132 AC171 AC172 AC211 AC212 AC341 AC342 AC472 AC662 AC692 AC782 AC791 AC792 AC812 AC861 AC862 AD042 AD272 AD391 AD392 CC41 DD22 DD23 DD27 EE06 EE07 EE35Continued front page F-term (reference) 4C083 AA122 AB172 AB242 AB472 AC102 AC122 AC132 AC171 AC172 AC211 AC212 AC341 AC342 AC472 AC662 AC692 AC782 AC791 AC792 AC812 AC861 AC862 AD042 AD272 AD391 AD392 CC41 DD22 DD23 DD27 EE06 EE07 EE35
Claims (4)
系界面活性剤の少なくとも1種を0.01〜5重量%、
サッカリンナトリウムとステビオサイドを重量比で1:
1〜8:1の割合で合計が0.01〜1重量%、並びに
バニリン、アネトール及びベンジルサクシネートから選
択される少なくとも1種を配合した口腔用組成物。 一般式(1): 【化1】 [式中、X1及びX2のいずれか一方がR1O−(AO)n
− 又は R1CO−B−(AO)n−であり、他方がM2
O−であり、M1およびM2はそれぞれ同一または異なっ
て、水素、アルカリ金属、アルカリ土類金属、アンモニ
ウム又はアルカノールアミンを表し、R1は炭素数8〜
22のアルキル基もしくはアルケニル基、AOは炭素数
2〜3のオキシアルキレン基、平均付加モル数nは0〜
20、Bは−NH−または炭素数2〜3のモノアルカノ
ールアミン残基を表す。]1. 0.01 to 5% by weight of at least one sulfosuccinic acid-based surfactant represented by the general formula (1),
Saccharin sodium and stevioside in a weight ratio of 1:
An oral composition containing 0.01 to 1% by weight in a ratio of 1 to 8: 1 and at least one selected from vanillin, anethole and benzyl succinate. General formula (1): [In the formula, one of X 1 and X 2 is R 1 O— (AO) n
- or R 1 CO-B- (AO) n - is and the other is M 2
O-, M 1 and M 2 are the same or different and each represent hydrogen, an alkali metal, an alkaline earth metal, ammonium or an alkanolamine, and R 1 has 8 to 8 carbon atoms.
22 alkyl groups or alkenyl groups, AO is an oxyalkylene group having 2 to 3 carbon atoms, and the average number n of added moles is 0.
20, B represents -NH- or a monoalkanolamine residue having 2 to 3 carbon atoms. ]
系界面活性剤のAO基の平均付加モル数nが0〜7であ
る請求項1記載の口腔用組成物。2. The oral composition according to claim 1, wherein the sulfosuccinic acid-based surfactant represented by the general formula (1) has an average number of added moles n of AO groups of 0 to 7.
系界面活性剤のアルキル基もしくはアルケニル基の炭素
数が10〜14である請求項1記載の口腔用組成物。3. The oral composition according to claim 1, wherein the alkyl group or the alkenyl group of the sulfosuccinic acid-based surfactant represented by the general formula (1) has 10 to 14 carbon atoms.
系界面活性剤のM1およびM2がナトリウムである請求項
1記載の口腔用組成物。4. The oral composition according to claim 1 , wherein M 1 and M 2 of the sulfosuccinic acid-based surfactant represented by the general formula (1) are sodium.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002196718A JP3803869B2 (en) | 2001-07-05 | 2002-07-05 | Oral composition |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001204792 | 2001-07-05 | ||
JP2001-204792 | 2001-07-05 | ||
JP2002196718A JP3803869B2 (en) | 2001-07-05 | 2002-07-05 | Oral composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2003081797A true JP2003081797A (en) | 2003-03-19 |
JP3803869B2 JP3803869B2 (en) | 2006-08-02 |
Family
ID=26618211
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2002196718A Expired - Lifetime JP3803869B2 (en) | 2001-07-05 | 2002-07-05 | Oral composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3803869B2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013245188A (en) * | 2012-05-25 | 2013-12-09 | Sunstar Inc | Liquid composition for oral cavity for stain formation inhibition having excellent storage stability |
JP2019073455A (en) * | 2017-10-12 | 2019-05-16 | サンスター株式会社 | Oral composition |
KR20200093439A (en) | 2017-11-30 | 2020-08-05 | 라이온 가부시키가이샤 | Oral Stain Remover, Oral Stain Formation Inhibitor and Oral Composition |
-
2002
- 2002-07-05 JP JP2002196718A patent/JP3803869B2/en not_active Expired - Lifetime
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013245188A (en) * | 2012-05-25 | 2013-12-09 | Sunstar Inc | Liquid composition for oral cavity for stain formation inhibition having excellent storage stability |
JP2019073455A (en) * | 2017-10-12 | 2019-05-16 | サンスター株式会社 | Oral composition |
JP7337481B2 (en) | 2017-10-12 | 2023-09-04 | サンスター株式会社 | oral composition |
KR20200093439A (en) | 2017-11-30 | 2020-08-05 | 라이온 가부시키가이샤 | Oral Stain Remover, Oral Stain Formation Inhibitor and Oral Composition |
Also Published As
Publication number | Publication date |
---|---|
JP3803869B2 (en) | 2006-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0569666B1 (en) | Composition comprising a monophosphate for use in the oral cavity | |
US7166272B2 (en) | Oral preparation | |
JP2003231622A (en) | Oral composition | |
JP2011140454A (en) | Composition for oral cavity | |
JP5528789B2 (en) | Liquid oral composition | |
KR20050013204A (en) | Compositions for oral cavity | |
CA2815639A1 (en) | Dual phase mouthwase | |
WO2008145475A1 (en) | Oral care composition | |
JP3419124B2 (en) | Oral composition | |
JPH1112142A (en) | Oral composition | |
JP2002179541A (en) | Composition for oral cavity containing cationic disinfectant | |
JP2627709B2 (en) | Oral composition | |
JP3855103B2 (en) | Oral composition | |
JP2013151473A (en) | Composition for oral cavity | |
JP2006104101A (en) | Composition for oral cavity | |
JP2003073282A (en) | Composition for oral cavity application | |
JP3803868B2 (en) | Oral composition | |
JP3803869B2 (en) | Oral composition | |
JP3753868B2 (en) | Oral composition | |
JP2003128540A (en) | Liquid composition for oral cavity | |
JP7558059B2 (en) | Oral Composition | |
JPH1112144A (en) | Liquid oral composition | |
JP2004175766A (en) | Teeth-whitening dentifrice composition | |
JP2007161657A (en) | Dentifrice composition | |
JP2006347986A (en) | Composition for oral cavity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050628 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060125 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20060412 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20060327 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20060424 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 3803869 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100519 Year of fee payment: 4 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110519 Year of fee payment: 5 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120519 Year of fee payment: 6 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130519 Year of fee payment: 7 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140519 Year of fee payment: 8 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |